{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:43:55Z","timestamp":1770288235516,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.atherosclerosis.2010.09.006","type":"journal-article","created":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T08:29:14Z","timestamp":1285144154000},"page":"241-246","source":"Crossref","is-referenced-by-count":18,"title":["Anti-inflammatory salicylate beneficially modulates pre-existing atherosclerosis through quenching of NF-\u03baB activity and lowering of cholesterol"],"prefix":"10.1016","volume":"213","author":[{"given":"Jitske","family":"de Vries-van der Weij","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Toet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Zadelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Y.","family":"Wielinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kleemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.N.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teake","family":"Kooistra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0005","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mnfr.200500081","article-title":"Hypercholesterolemia and inflammation in atherogenesis: two sides of the same coin","volume":"49","author":"Steinberg","year":"2005","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0010","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0020","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/hq1201.100260","article-title":"Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice","volume":"21","author":"Davis","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0025","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.CIR.0000086460.55494.AF","article-title":"Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin","volume":"108","author":"Kleemann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"Mach","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.ATV.0000148866.29829.19","article-title":"Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice","volume":"25","author":"Verschuren","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0021-9150(98)00263-9","article-title":"Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study","volume":"143","author":"Gijbels","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0045","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/01.ATV.19.9.2162","article-title":"Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice","volume":"19","author":"Tsukamoto","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1194\/jlr.M800374-JLR200","article-title":"LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice:time course and mechanisms","volume":"50","author":"Verschuren","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0055","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1073\/pnas.0511043103","article-title":"Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice","volume":"103","author":"Trogan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0060","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2459\/JCM.0b013e3282f447c3","article-title":"Aortic plaque regression as determined by magnetic resonance imaging with high-dose and low-dose statin therapy","volume":"9","author":"Gottlieb","year":"2008","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0075","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/gb-2007-8-9-r200","article-title":"Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis","volume":"8","author":"Kleemann","year":"2007","journal-title":"Genome Biol"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0080","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","article-title":"Mouse models for atherosclerosis and pharmaceutical modifiers","volume":"27","author":"Zadelaar","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0085","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1194\/jlr.M500434-JLR200","article-title":"Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL","volume":"47","author":"Westerterp","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0090","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/01.ATV.0000238348.05028.14","article-title":"Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol","volume":"26","author":"Kooistra","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2009.02.038","article-title":"Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice","volume":"206","author":"de Vries-van der Weij","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0100","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.2174\/1381612043383638","article-title":"The role of STATs in inflammation and inflammatory diseases","volume":"10","author":"Pfitzner","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0105","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/eurheartj\/ehi175","article-title":"Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition\u2014a magnetic resonance imaging study","volume":"26","author":"Viles-Gonzalez","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0110","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200318580","article-title":"Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice","volume":"112","author":"Kanters","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0115","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1182\/blood-2003-05-1450","article-title":"Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype","volume":"103","author":"Kanters","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0120","doi-asserted-by":"crossref","first-page":"18601","DOI":"10.1073\/pnas.0709011104","article-title":"The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes","volume":"104","author":"Wolfrum","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0125","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.0000027816.54430.96","article-title":"Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice","volume":"106","author":"Cyrus","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2003-07-2412","article-title":"Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression","volume":"103","author":"Chen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2010.09.006_bib0135","first-page":"891","article-title":"Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes","volume":"151","author":"Bellas","year":"1997","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2010.09.006_bib0140","doi-asserted-by":"crossref","first-page":"e8817","DOI":"10.1371\/journal.pone.0008817","article-title":"Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance","volume":"5","author":"Kleemann","year":"2010","journal-title":"PLoS One"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010007343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010007343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:22:12Z","timestamp":1559694132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915010007343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0021915010007343"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.09.006","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}